<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">65905</article-id><article-id pub-id-type="doi">10.7554/eLife.65905</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cancer Biology</subject></subj-group></article-categories><title-group><article-title>Convergent organization of aberrant MYB complex controls oncogenic gene expression in acute myeloid leukemia</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-219310"><name><surname>Takao</surname><given-names>Sumiko</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-219311"><name><surname>Forbes</surname><given-names>Lauren</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-219312"><name><surname>Uni</surname><given-names>Masahiro</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-219313"><name><surname>Cheng</surname><given-names>Shuyuan</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-128548"><name><surname>Pineda</surname><given-names>Jose Mario Bello</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-1417-9200</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-219314"><name><surname>Tarumoto</surname><given-names>Yusuke</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-6652-9618</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-223634"><name><surname>Cifani</surname><given-names>Paolo</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-219316"><name><surname>Minuesa</surname><given-names>Gerard</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-219317"><name><surname>Chen</surname><given-names>Celine</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-22401"><name><surname>Kharas</surname><given-names>Michael G</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-117192"><name><surname>Bradley</surname><given-names>Robert K</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8046-1063</contrib-id><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-205846"><name><surname>Vakoc, MD, PhD</surname><given-names>Christopher</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-54520"><name><surname>Koche</surname><given-names>Richard P</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-6820-5083</contrib-id><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-39332"><name><surname>Kentsis</surname><given-names>Alex</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8063-9191</contrib-id><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf2"/></contrib><aff id="aff1"><institution content-type="dept">SKI</institution>, <institution>Memorial Sloan Kettering Cancer Center</institution>, <addr-line><named-content content-type="city">New York</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><institution content-type="dept">Division of Basic Sciences</institution>, <institution>Fred Hutchinson Cancer Research Center</institution>, <addr-line><named-content content-type="city">Seattle</named-content></addr-line>, <country>United States</country></aff><aff id="aff3"><institution content-type="dept">Institute for Frontier Life and Medical Sciences</institution>, <institution>Kyoto University</institution>, <addr-line><named-content content-type="city">Kyoto</named-content></addr-line>, <country>Japan</country></aff><aff id="aff4"><institution content-type="dept">Molecular Pharmacology and Chemistry</institution>, <institution>Memorial Sloan Kettering Cancer Center</institution>, <addr-line><named-content content-type="city">New York</named-content></addr-line>, <country>United States</country></aff><aff id="aff5"><institution content-type="dept">Computational Biology Program, Public Health Sciences Division</institution>, <institution>Fred Hutchinson Cancer Research Center</institution>, <addr-line><named-content content-type="city">Seattle</named-content></addr-line>, <country>United States</country></aff><aff id="aff6"><institution>Cold Spring Harbor Laboratory</institution>, <addr-line><named-content content-type="city">Cold Spring Harbor</named-content></addr-line>, <country>United States</country></aff><aff id="aff7"><institution content-type="dept">Cancer Biology and Genetics Program</institution>, <institution>Memorial Sloan Kettering Cancer Center</institution>, <addr-line><named-content content-type="city">New York</named-content></addr-line>, <country>United States</country></aff><aff id="aff8"><institution content-type="dept">Molecular Pharmacology Program, Sloan Kettering Institute</institution>, <institution>Memorial Sloan Kettering Cancer Center</institution>, <addr-line><named-content content-type="city">New York</named-content></addr-line>, <country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-14864"><name><surname>Davidson</surname><given-names>Irwin</given-names></name><role>Reviewing editor</role><aff><institution>Institut de Génétique et de Biologie Moléculaire et Cellulaire</institution>, <country>France</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>kentsisresearchgroup@gmail.com</email> (AK);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>02</day><month>02</month><year>2021</year></pub-date><volume>10</volume><elocation-id>e65905</elocation-id><history><date date-type="received"><day>18</day><month>12</month><year>2020</year></date><date date-type="accepted"><day>01</day><month>02</month><year>2021</year></date></history><permissions><copyright-statement>© 2021, Takao et al</copyright-statement><copyright-year>2021</copyright-year><copyright-holder>Takao et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-65905-v1.pdf"/><abstract><p>Dysregulated gene expression contributes to most prevalent features in human cancers. Here, we show that most subtypes of acute myeloid leukemia (AML) depend on the aberrant assembly of MYB transcriptional co-activator complex. By rapid and selective peptidomimetic interference with the binding of CBP/P300 to MYB, but not CREB or MLL1, we find that the leukemic functions of MYB are mediated by CBP/P300 co-activation of a distinct set of transcription factor complexes. These MYB complexes assemble aberrantly with LYL1, E2A, C/EBP family members, LMO2 and SATB1. They are organized convergently in genetically diverse subtypes of AML, and are at least in part associated with inappropriate transcription factor co-expression. Peptidomimetic remodeling of oncogenic MYB complexes is accompanied by specific proteolysis and dynamic redistribution of CBP/P300 with alternative transcription factors such as RUNX1 to induce myeloid differentiation and apoptosis. Thus, aberrant assembly and sequestration of MYB:CBP/P300 complexes provide a unifying mechanism of oncogenic gene expression in AML. This work establishes a compelling strategy for their pharmacologic reprogramming and therapeutic targeting for diverse leukemias and possibly other human cancers caused by dysregulated gene control.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R01 CA204396</award-id><principal-award-recipient><name><surname>Kentsis</surname><given-names>Alex</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>P30 CA008748</award-id><principal-award-recipient><name><surname>Kentsis</surname><given-names>Alex</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>T32 GM073546</award-id><principal-award-recipient><name><surname>Forbes</surname><given-names>Lauren</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Alex Kentsis, AK is a consultant for Novartis and Rgenta. A patent application related to this work has been submitted to the U.S. Patent and Trademark Office entitled 'Agents and methods for treating CREB binding protein-dependent cancers' (application PCT/US2017/059579)..</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>All supplemental data are available openly via Zenodo (https://doi.org/10.5281/zenodo. 4321824). Mass spectrometry proteomics data are available via PRIDE (PXD019708). Gene expression and chromatin dynamics data are available via Gene Expression Omnibus (GSE163470).</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Sumiko Takao</collab><collab>Lauren Forbes</collab><collab>Masahiro Uni</collab><collab>Paolo Cifani</collab><collab>Richard P Koche</collab><collab>Alex Kentsis</collab></person-group><year iso-8601-date="2020">2020</year><source>Supplementary Data for</source><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.5281/zenodo.4321824">https://doi.org/10.5281/zenodo.4321824</ext-link><comment>Zenodo, 4321824</comment></element-citation><element-citation id="dataset2" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Alex Kentsis</collab></person-group><year iso-8601-date="2020">2020</year><source>Definition of aberrant MYB CBP/P300 complex in AML</source><ext-link ext-link-type="uri" xlink:href="https://www.ebi.ac.uk/pride/archive/projects/PXD019708">https://www.ebi.ac.uk/pride/archive/projects/PXD019708</ext-link><comment>PRIDE, PXD019708</comment></element-citation><element-citation id="dataset3" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Richard P Koche</collab><collab>Lauren Forbes</collab><collab>Sumiko Takao</collab><collab>Jose Mario Bello Pineda</collab><collab>Robert K Bradley</collab><collab>Alex Kentsis</collab></person-group><year iso-8601-date="2020">2020</year><source>Convergent organization of aberrant MYB complexes controls oncogenic gene expression in acute myeloid leukemia</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE163470">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE163470</ext-link><comment>NCBI Gene Expression Omnibus, GSE163470</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-65905-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>